您的当前位置:首页 > 行业数据 > 2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力
图片属性
图片格式:PNG 图片大小:272KB 图片尺寸:2303*1198
同报告图片
 / 4
2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力_第1页
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
2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力_第2页
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
2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力_第3页
2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力_第4页
2L+EC治疗数据:DB-1303相比临床现有方案展现疗效与安全性优势,且展现相比Enhertu的更优潜力_第5页
所属报告: 映恩生物~B-港股公司首次覆盖报告:创新驱动ADC新秀迈向全球舞台-250420(43页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠